Advanced company searchLink opens in new window

I-PHARM CONSULTING LIMITED

Company number 06540985

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
30 Sep 2024 AA Full accounts made up to 31 December 2023
04 Sep 2024 CH01 Director's details changed for Mr Stephen Peter Mcananey on 4 February 2022
28 Jun 2024 CH01 Director's details changed for Mr Colin John Lynam on 1 March 2021
27 Mar 2024 CS01 Confirmation statement made on 20 March 2024 with no updates
17 Dec 2023 AA Full accounts made up to 31 December 2022
18 Oct 2023 PSC05 Change of details for I-Pharm Consulting Group Limited as a person with significant control on 18 October 2023
18 Oct 2023 AD01 Registered office address changed from 3rd Floor, 52 Bedford Row London WC1R 4LR England to Level 7 8 Devonshire Square London EC2M 4YJ on 18 October 2023
12 May 2023 CH01 Director's details changed for Mr Issam Adil Al-Tarafi on 28 September 2022
20 Mar 2023 CS01 Confirmation statement made on 20 March 2023 with no updates
08 Mar 2023 PSC05 Change of details for I-Pharm Consulting Group Limited as a person with significant control on 24 October 2022
24 Oct 2022 AD01 Registered office address changed from 3rd Floor, 52 Bedford Row Bedford Row London WC1R 4LR England to 3rd Floor, 52 Bedford Row London WC1R 4LR on 24 October 2022
24 Oct 2022 AD01 Registered office address changed from 3rd Floor 22 Long Acre London WC2E 9LY England to 3rd Floor, 52 Bedford Row Bedford Row London WC1R 4LR on 24 October 2022
30 Sep 2022 AA Full accounts made up to 31 December 2021
23 Mar 2022 CS01 Confirmation statement made on 20 March 2022 with updates
01 Dec 2021 AD01 Registered office address changed from The Warehouse 212 New King’S Road London SW6 4NZ United Kingdom to 3rd Floor 22 Long Acre London WC2E 9LY on 1 December 2021
13 Sep 2021 AA Full accounts made up to 31 December 2020
10 Aug 2021 RESOLUTIONS Resolutions
  • RES12 ‐ Resolution of varying share rights or name
  • RES13 ‐ Sub division 12/07/2021
08 Aug 2021 SH08 Change of share class name or designation
08 Aug 2021 SH02 Sub-division of shares on 13 July 2021
08 Aug 2021 SH01 Statement of capital following an allotment of shares on 13 July 2021
  • GBP 114.3215
27 Apr 2021 CS01 Confirmation statement made on 20 March 2021 with no updates
18 Nov 2020 AA Accounts for a small company made up to 31 December 2019
07 Apr 2020 CS01 Confirmation statement made on 20 March 2020 with updates
16 Mar 2020 PSC05 Change of details for I-Pharm Consulting Group Limited as a person with significant control on 26 February 2020
16 Mar 2020 PSC07 Cessation of Stephen Peter Mcananey as a person with significant control on 26 February 2020